Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clin Geriatr Med ; 38(3): 501-517, 2022 08.
Article in English | MEDLINE | ID: mdl-35868669

ABSTRACT

Patients with cognitive impairment have paid a heavy price for the coronavirus disease 2019 pandemic. Their clinical characteristics and their place of life made them particularly exposed to being infected and suffering from severe forms. The repercussions of the isolation measures also had significant repercussions on the expression of their neuropsychiatric symptoms and the burden on families and health care professionals.


Subject(s)
COVID-19 , Cognitive Dysfunction , Coronavirus , Aged , Cognitive Dysfunction/diagnosis , Health Personnel , Humans , Pandemics
3.
Article in English | MEDLINE | ID: mdl-34199566

ABSTRACT

The World Health Organization has developed the Integrated Care of Older People (ICOPE) strategy, a program based on the measurement of intrinsic capacity (IC) as "the composite of all physical and mental attributes on which an individual can draw". Multicomponent interventions appear to be the most effective approach to enhance IC and to prevent frailty and disability since adapted physical activity is the preventive intervention that has shown the most evidence in the treatment of frailty and risk of falls. Our paper describes the development of a multi-domain group-based intervention addressed to older people living in the community, aimed at improving and/or maintaining intrinsic capacity by means of promoting physical activity, healthy nutrition, and psychological wellbeing in older people. The process of intervention development is described following the Guidance for reporting intervention development studies in health research (GUIDED). The result of this study is the AMICOPE intervention (Aptitude Multi-domain group-based intervention to improve and/or maintain IC in Older PEople) built upon the ICOPE framework and described following the Template for Intervention Description and Replication (TIDieR) guidelines. The intervention consists of 12 face-to-face sessions held weekly for 2.5 h over three months and facilitated by a pair of health and social care professionals. This study represents the first stage of the UK Medical Research Council framework for developing and evaluating a complex intervention. The next step should be carrying out a feasibility study for the AMICOPE intervention and, at a later stage, assessing the effectiveness in a randomized controlled trial.


Subject(s)
Diet, Healthy , Frailty , Accidental Falls , Aged , Exercise , Humans , World Health Organization
4.
J Evid Based Complementary Altern Med ; 22(4): 637-645, 2017 10.
Article in English | MEDLINE | ID: mdl-28508664

ABSTRACT

In the present study, the aphrodisiac properties of the purple corn ( Zea mays) in male rats were analyzed. The aqueous crude extract of purple corn (at 25, 50, and 75 mg/kg) was administered to ( a) copulating male rats and ( b) anesthetized and spinal cord transected male rats. Behavioral parameters of copulatory behavior and parameters of the genital motor pattern of ejaculation previous to its inhibition, under the influence of the purple corn extract, are described. Administration of the aqueous crude extract of purple corn significantly facilitates the arousal and execution of male rat sexual behavior without significant influences on the ambulatory behavior. In addition, purple corn extract elicit a significant increase in the number of discharges of the ejaculatory motor patterns and in the total number of genital motor patterns evoked in spinal rats. The present findings show that the aqueous crude extract of purple corn possesses aphrodisiac activity.


Subject(s)
Aphrodisiacs/pharmacology , Plant Extracts/pharmacology , Zea mays , Animals , Copulation/drug effects , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Sexual Behavior, Animal/drug effects
5.
Int J Geriatr Psychiatry ; 28(8): 795-803, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23147419

ABSTRACT

OBJECTIVE: Behavioral and psychological symptoms of dementia represent common clinical features of dementias, contributing to the heterogeneous phenotypic expression of Alzheimer's disease (AD). During the last two decades, several studies explored the possible presence of neuropsychiatric subsyndromes in dementia by examining the internal structure of the Neuropsychiatric Inventory (NPI). The aim of the present review is to present available evidence coming from studies adopting factor analysis to explore the NPI and describe neuropsychiatric clusters of symptoms in AD. DESIGN: A systematic review of literature was performed concerning available studies describing neuropsychiatric subsyndromes in AD by adopting the NPI. RESULTS: Overall, our analysis showed a relatively low concordance among available evidence for what concerns the definition and composition of NPI clusters, possibly due (at least in part) to the heterogeneity of the sample populations recruited in the studies. However, we also observed some consistent associations of specific symptoms across studies, defining potential subsyndromes in AD. More consistent results were obtained by studies evaluating the 10-item version of the NPI rather than the more recent 12-item one. CONCLUSIONS: This review represents the first attempt to systematically evaluate evidence coming from factor analyses exploring the internal structure of the NPI in order to facilitate the identification of neuropsychiatric syndromes in AD patients. The NPI may support the definition of behavioral subsyndromes in AD. The evaluation of neuropsychiatric subsyndromes should always take into account the main potential confounders, such as age, severity of disease, and concomitant pharmacological treatment.


Subject(s)
Alzheimer Disease/psychology , Apathy , Emotions , Factor Analysis, Statistical , Humans , Mental Disorders/psychology , Neuropsychological Tests , Psychomotor Agitation/psychology
6.
J Am Med Dir Assoc ; 13(4): 407.e1-6, 2012 May.
Article in English | MEDLINE | ID: mdl-22227074

ABSTRACT

OBJECTIVES: The aim of this study was to explore the predictive value of an abnormal one-leg balance (OLB) test for functional decline, nursing home admission, and mortality in community-dwelling patients affected with Alzheimer's disease (AD). DESIGN: A 2-year prospective, observational cohort study. SETTING: Nineteen memory centers across France. PARTICIPANTS: A total of 686 community-dwelling patients with AD. MEASUREMENTS: Mini-mental state examination, Activity of Daily Living scale, and balance (ability to stand unassisted for 5 seconds on 1 leg) were reported every 6 months. Functional decline was defined as a loss of 0.5 or more points at a 5-point Activity of Daily Living score (bathing, dressing, toileting, continence, and feeding). Nursing home admission and mortality were recorded. Neuropsychiatric symptoms, medication, and caregiver's burden were assessed every 6 months. Time-to-event analyses were used. RESULTS: At baseline, 632 patients with AD had a balance measurement (mean age = 77.8 years, SD = 6.9; 72.2% were women) and 15.2% had an abnormal OLB test: these patients were older, had lower mini-mental state examination and Activity of Daily Living scores, and more neuropsychiatric symptoms, osteoarthritis, comorbidities and medications (all P < .05). After adjustment for age and sex, the risk of functional decline (hazard ratio [HR]: 1.69; 95% confidence interval [CI], 1.26-2.26), nursing home admission (HR: 2.51; 95% CI, 1.69-3.73), and death (HR: 2.42; 95% CI, 1.43-4.11) was higher in patients with an abnormal OLB. After adjustment for other potential confounders, the presence of an abnormal OLB was significantly associated only with nursing home admission (HR: 1.73, 95% CI, 1.09-2.75). CONCLUSION: In the present study, an abnormal OLB predicts nursing home admission in patients with AD. Although statistically significant when solely adjusted for age and sex, an abnormal OLB test failed to predict functional decline and mortality when adjusted for multiple confounders.


Subject(s)
Alzheimer Disease/diagnosis , Leg , Patient Admission/statistics & numerical data , Postural Balance/physiology , Sensation Disorders/diagnosis , Activities of Daily Living , Aged , Aged, 80 and over , Alzheimer Disease/complications , Alzheimer Disease/mortality , Aptitude Tests , Cohort Studies , Confidence Intervals , Disease Progression , Female , France , Humans , Independent Living/statistics & numerical data , Male , Middle Aged , Multivariate Analysis , Neuropsychological Tests , Nursing Homes/statistics & numerical data , Physical Examination/methods , Predictive Value of Tests , Prognosis , Prospective Studies , Residence Characteristics , Risk Assessment , Sensation Disorders/etiology , Severity of Illness Index , Survival Analysis , Time Factors
7.
BMC Public Health ; 12: 68, 2012 Jan 23.
Article in English | MEDLINE | ID: mdl-22269343

ABSTRACT

BACKGROUND: Health care policies in many countries aim to enable people with dementia to live in their own homes as long as possible. However, at some point during the disease the needs of a significant number of people with dementia cannot be appropriately met at home and institutional care is required. Evidence as to best practice strategies enabling people with dementia to live at home as long as possible and also identifying the right time to trigger admission to a long-term nursing care facility is therefore urgently required. The current paper presents the rationale and methods of a study generating primary data for best-practice development in the transition from home towards institutional nursing care for people with dementia and their informal caregivers. The study has two main objectives: 1) investigate country-specific factors influencing institutionalization and 2) investigate the circumstances of people with dementia and their informal caregivers in eight European countries. Additionally, data for economic evaluation purposes are being collected. METHODS/DESIGN: This paper describes a prospective study, conducted in eight European countries (Estonia, Finland, France, Germany, Netherlands, Sweden, Spain, United Kingdom). A baseline assessment and follow-up measurement after 3 months will be performed. Two groups of people with dementia and their informal caregivers will be included: 1) newly admitted to institutional long-term nursing care facilities; and 2) receiving professional long-term home care, and being at risk for institutionalization. Data will be collected on outcomes for people with dementia (e.g. quality of life, quality of care), informal caregivers (e.g. caregiver burden, quality of life) and costs (e.g. resource utilization). Statistical analyses consist of descriptive and multivariate regression techniques and cross-country comparisons. DISCUSSION: The current study, which is part of a large European project 'RightTimePlaceCare', generates primary data on outcomes and costs of long-term nursing care for people with dementia and their informal caregivers, specifically focusing on the transition from home towards institutional care. Together with data collected in three other work packages, knowledge gathered in this study will be used to inform and empower patients, professionals, policy and related decision makers to manage and improve health and social dementia care services.


Subject(s)
Dementia , Home Care Services , Institutionalization , Nursing Homes , Patient Transfer , Aged , Caregivers , Cohort Studies , Cost of Illness , Europe , Female , Humans , Male , Prospective Studies , Quality of Health Care
8.
J Sex Med ; 9(4): 1015-26, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21676185

ABSTRACT

INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) are antidepressants that cause sexual dysfunction. The SSRI fluoxetine (FLX) appears to particularly affect the ejaculatory response. Ejaculation is regulated both at brain and spinal levels. AIM: To study the acute and chronic effects of FLX on male rat copulatory behavior, trying to distinguish between brain and spinal cord FLX-induced changes on the ejaculatory response. METHODS: Sexually experienced male rats were intraperitoneally injected with 5 or 10 mg/kg FLX and tested for sexual behavior during 60 minutes on days 1, 7, and 14 of treatment. After a 2-day drug holiday, the males chronically treated with the high FLX dose were spinalized to record spontaneous and mechanically evoked genital motor patterns of ejaculation (GMPEs). In addition, independent groups were used to evaluate the acute effects of 1, 3, or 10 µg/rat FLX (intravenously) on the GMPE. MAIN OUTCOME MEASURES: Number of ejaculatory series and their parameters; electromyographic recordings of the GMPE in the bulbospongiosus muscles and their parameters. RESULTS: Acute FLX injection slightly affected sexual behavior display and dose-dependently inhibited the expression of the GMPE. Chronic FLX treatment did not inhibit copulation but produced deficits in the parameters related to ejaculation after the high dose. In these animals, the response capacity of the spinal generator of ejaculation (SGE) as well as the number of discharges in the GMPE was decreased as a result of chronic FLX treatment. CONCLUSIONS: Chronic FLX treatment produces inhibitory effects on male rat copulation, particularly on ejaculation, some of which are exerted directly at the SGE.


Subject(s)
Antidepressive Agents, Second-Generation/pharmacology , Copulation/drug effects , Ejaculation/drug effects , Fluoxetine/pharmacology , Sexual Behavior, Animal/drug effects , Animals , Brain/drug effects , Dose-Response Relationship, Drug , Electromyography/drug effects , Injections, Intraperitoneal , Male , Motor Activity/drug effects , Rats, Wistar , Spinal Cord/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...